Design of the ATAQ peptide and its evaluation as an immunogen to develop a Rhipicephalus vaccine

Veterinary Parasitology

Volumn 221, Issue , 2016, Pages 30-38

  Aguirre, André de Abreu Rangel ^a,e   Lobo, Francisco Pereira ^b   Cunha, Rodrigo Casquero ^a,c   Garcia, Marcos Valério ^c,d   Andreotti, Renato ^c  

^a FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^b EMBRAPA INFORMÁTICA AGROPECUÁRIA   (Brazil)

^c EMBRAPA CERRADOS   (Brazil)

^d Fellow of the National Research Council   (Brazil)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

ATAQ; Immunization; Reverse vaccinology; Rhipicephalus microplus; Rhipicephalus sanguineus; Synthetic peptide

Indexed keywords

ANTIGEN; ATAQ PEPTIDE; RHIPICEPHALUS VACCINE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VACCINE; ANTIBODY; ARTHROPOD PROTEIN; PEPTIDE; RECOMBINANT VACCINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BIOINFORMATICS; BOVINE; CONTROLLED STUDY; DNA SEQUENCE; DRUG DESIGN; DRUG EFFICACY; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; LIFE CYCLE; MALE; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PROTEIN ANALYSIS; PROTEIN ISOLATION; RABBIT; REVERSE VACCINOLOGY; RHIPICEPHALUS (BOOPHILUS) MICROPLUS; RHIPICEPHALUS SANGUINEUS; SEQUENCE ALIGNMENT; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CATTLE DISEASES; CHEMISTRY; GENETICS; IMMUNOLOGY; RABBITS AND HARES; RANDOMIZATION; RHIPICEPHALUS; STANDARDS; TICK INFESTATIONS; VETERINARY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ARTHROPOD PROTEINS; CATTLE; CATTLE DISEASES; FEMALE; MALE; MICE; MICE, INBRED BALB C; PEPTIDES; RABBITS; RANDOM ALLOCATION; RHIPICEPHALUS; SEQUENCE ALIGNMENT; TICK INFESTATIONS; VACCINES; VACCINES, SYNTHETIC;

EID: 84960343485     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2016.02.032     Document Type: Article

References (42)

1. Adu-Bobie J., Capecchi B., Serruto D., Rappouli R., Pizza M. Two years into reverse vaccinology. Vaccine 2003, 21:605-610.
2. Andreotti R., Gomes A., Malavazi-Puza K.C., Sasaki S.D., Sampaio C.A.M., Tanaka A.S. BmTI antigens induce a bovine protective immune response against Boophilus microplus tick. Int. Immunopharmacol. 2002, 2:557-563.
3. Andreotti R., Cunha R.C., Soares M.A., Guerrero F.D., Leite F.P.L., Pérez De León A.A. Protective immunity against tick infestation in cattle vaccined with recombinant trypsin inhibitor of Rhipicephalus microplus. Vaccine 2012, 30:6678-6685.
4. Andreotti R. Performance of two Bm86 antigen vaccin formulation against tick using crossbreed bovines in stall test. Rev. Bras. Parastiol. Vet. 2006, 15(3):97-100.
5. Andreotti R. A synthetic bmti n-terminal fragment as antigen in bovine immunoprotection agains the tick Boophilus microplus in a pen trial. Exp. Parasitol. 2007, 116(1):66-70.
6. Bechara G.H., Szabó M.P.J., Ferreira B.R., Garcia M.V. Rhipicephalus sanguineus tick in brazil: feeding and reproductive aspects under laboratorial conditions. Rev. Bras. Parasitol. Vet. 1995, 4(2):61-66.
7. Briand J.P., Muller S., Van Regenmortel M.H.V. Synthetic peptides as antigens: pitfalls of conjugation methods. J. Immunol. Methods 1985, 78:59-69.
8. Canales M., Enríquez A., Ramos E., Cabrera D., Dandie H., Soto A., Falcón V., Rodríguez M., de la Fuente J. Large-scale production in Pichia pastoris of the recombinant vaccine Gavac against cattle tick. Vaccine 1997, 15(4):414-422.
9. Carreón D., De La Lastra J.M.P., Almazán C., Canales M., Ruiz-Fons F., Boadella M., Moreno-Cid J.A., Villar M., Gortázar C., Reglero M., Villarreal R., de la Fuente J. Vaccination with Bm86: subolesin and akirin protective antigens for the control of tick infestations in White tailed deer and red deer. Vaccine 2012, 30(20):273-279.
10. Cunha R.C., Pérez De León A.A., Leie F.P.L., Pinto L.S., Santos Júnior A.G., Andreotti R. Bovine immunoprotection against Rhipicephalus microplus with recombinant Bm86-Campo Grande antigen. Rev. Bras. Parasitol. Vet. 2012, 21(3):254-262.
11. De La Fuente J., Kocan K.M. Strategies for development of vaccines for control of ixodid tick species. Parasite Immunol. 2006, 28:275-283.
12. De La Fuente J.L., Rodríguez M., Montero C., Redondo M., García-García J.C., Méndez L., Serrano E., Valdés M., Enríquez A., Canales M., Ramos E., Boué O., Machado H., Lleonart R. Vacination against ticks (Boophilus spp.); the experience with the Bm86-based vaccine Gavac™. Genet. Anal. Biomol. E 1999, 15:143-148.
13. De La Fuente J., Almazán C., Canales M., De La Lastra J.M.P., Kocan K.M., Willadsen P. A ten-year review of commercial vaccine performance for control of tick infestation on cattle. Anim. Health. Res. Rev. 2007, 8(1):23-28.
14. De Silva B.S., Egodage K.L., Wilson G.S. Purified protein derivative (PPD) as an immunogen carrier elicits high antigen specificity to haptens. Bioconjug. Chem. 1999, 10:496-501.
15. Friede M., Muller S., Briand J.P., Van Regenmortel M.H.V., Schuber F. Induction of immune response against a short synthetic peptide antigen coupled to small neutral liposomes containing monophosphoryl lilip A. Mol. Immunol. 1993, 30(6):539-547.
16. Garcia-Garcia J.C., González I.I., González D.M., Valdés M., Méndez L., Lamberti J., DAgostino B., Citroni D., Fragoso H., Ortíz M., Rodríguez M., De la Fuente J. Sequence variations in the Boophilus microplus Bm86 locus and implications for immunoprotection in cattle vaccinated with this antigen. Exp. Appl. Acarol. 1999, 23:883-895.
17. Geer L.Y., Marchler-Bauer A., Geer R.C., Han L., He J., He S., Liu C., Shi W., Bryant S.H. The NCBI BioSystems database. Nucleic Acids Res. 2010, 38:492-496.
18. Germain R.N., Margulies D.H. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 1993, 11:403-450.
19. Gough J.M., Kemp D.H. Localization of a low abundance membrane protein (Bm86) on the gut cells of the cattle tick Boophilus microplus by immunogold labeling. J. Parasitol. 1993, 79:900-907.
20. Hemmer B., Kondo T., Gran B., Pinilla C., Cortese I., Pascal J., Tzou A., McFarland H.F., Houghten R., Martin R. Minimal peptide length requirements for CD4+ T cell clones -implications for molecular mimicry and T cell survival. Int. Immunol. 2000, 12(3):375-383.
21. Kopp N., Diaz D., Amacker M., Odongo D.O., Beier K., Nitsch C., Bishop R.P., Daubenberger C.A. Identification of a synthetic peptide inducing cross-reactive antibodies binding to Rhipicephalus (Boophilus) decoloratus, Rhipicephalus microplus, Hyalomma anatolicum anatolicum and Rhipicephalus appendiculatus Bm86 homologues. Vaccine 2010, 28(1):261-269.
22. Maritz-Olivier C., Zyl W.V., Stutzer C. A systematic, functional genomics, and reverse vaccinology approach to the identification of vaccine candidates in the cattle tick: Rrhipicepalus microplus. Ticks Tick Borne Dis. 2012, 3:179-187.
23. Nene V., Svitek N., Toye P., Golde W.T., Barlow J., Harndahl M., Buus S., Nielsen M. Designing bovine T cell vaccines via reverse immunology. Ticks Tick Borne Dis. 2012, 3:188-192.
24. Nijhof A.M., Taoufik A., De La Fuente J., Kocam K.M., Vries E., Jongejan F. Gene silencing of the tick protective antigens, Bm86, Bm91 and subolesin: in the one-host tick Boophilus microplus by RNA interference. Int. J. Parasitol. 2006, 37:653-662.
25. Nijhof A.M., Balk J.A., Postigo M., Rhebergen A.M., Taoufik A., Jongejan F. Bm86 homologues and novel ATAQ proteins with multiple epidermal growth factor (EGF)-like domains from hard and soft ticks. Int. J. Parasitol. 2010, 40:1587-1597.
26. Patarroyo J.H., Portela R.W., De Castro R.O., Pimentel C., Guzman F., Patarroyo M.E., Vargas M.E., Prates A.A., Dias Mendes M.A. Immunization of cattle with synthetic peptides derived from the Boophilus microplus gut protein (Bm86). Vet. Immunol. Immunopathol. 2002, 88:163-172.
27. Prinz D.M., Smithson S.L., Westerink M.A.J. Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C. J. Immunol. Methods 2004, 285:1-14.
28. Prudencio C.R., Marra A.O.M., Cardoso R., Goulart L.R. Recombinant peptides as new immunogens for the control of the bovine tick Rhipicephalus microplus. Vet. Parasitol. 2010, 172(1-2):122-131.
29. Rand K.N., Moore T., Sriskantha A., Spring K., Tellam R., Willadsen P., Cobon G.S. Cloning and expression of a protective antigen from the cattle tick Boophilus microplus. Proc. Natl. Acad. Sci. U. S. A. 1989, 86(24):9657-9661.
30. Rappouli R. Reverse vaccinology. Curr. Opin. Microbiol. 2000, 3:445-450.
31. Richardson M.A., Smith D.R., Kemp D.H., Tellam R.L. Native and baculovirus-expressed forms of the immuno-protective protein Bm86 from Boophilus micoplus are anchored to the cell membrane by a glycosyl-phosphatidyl inositol linkage. Insect. Mol. Biol. 1993, 1(3):139-147.
32. Rodríguez-Mallon A., Fernández E., Encinosa P.E., Bello Y., Méndez-Pérez L., Ruiz L.C., Pérez D., González M., Garay H., Reyes O., Méndez L., Estrada M.P. A novel tick antigen shows high vaccine efficacy against the dog tick, Rhipicephalus sanguineus. Vaccine 2012, 30(10):1782-1789.
33. Rodriguez-Valle M., Moolhuijzen P., Piper E.K., Weiss O., Vance M., Bellgard M., Lew-Tabor A. Rhipicephalus microplus lipocalins (LRMs): Genomic identification and analysis of the bovine immune response using in silico predicted B and T cell epitopes. Int. J. Parasitol. 2013, 43:739-752.
34. Rodríguez-Valle M., Canan-Hadden L., Niebla O. Immunization and chemical conjugation of Bm95 obtained from Pichia pastoris enhances the immune response against vaccinal protein and Neisseria meningitidis capsular polysaccharide. Vaccine (Auckl.) 2014, 4:15-22.
35. Rodriguez M., Penichet M.L., Mouris A.E., Labarta V., Luaces L.L., Rubiera R., Cordovés C., Sánchez P.A., Ramos E., Soto A., Canales M., Palenzuela D., Triguero A., Lleonard R., Herrera L., de la Fuente J. Control of Boophilus microplus populations in grazing cattle vaccinated with a recombinant Bm86 antigen preparation. Vet. Parasitol. 1995, 57:339-349.
36. Sasaki S.D., Tanaka A.S. rBmTI-6 a Kunitz-BPTI domain protease inhibtor from the tick Boophilus microplus, its cloning, expression and biochemical characterization. Vet. Parasitol. 2008, 155:133-141.
37. Tanaka A.S., Andreotti R., Gomes A., Torquato R.J.S., Sampaio M.U., Sampaio C.A.M. A doublé headed serine proteinase inhibtor -human plasma kallikrein and elastase inhibtor-from Boophilus microplus. Immunopharmacol 1999, 45:171-177.
38. Toes R.E.M., Offringa R., Blom R.J.J., Melief C.J.M., Kast W.M. Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:7855-7860.
39. Van Houten N.E., Zwick M.B., Menendez A., Scott J.K. Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide. Vaccine 2006, 24:4188-4200.
40. Vordermeier M., Whelan A.O., Hewinson R.G. Recognition of mycobacterial epitopes by t cells across mammalian species an use of a program that predicts human HLA-DR binding peptides to predict bovine epitopes. Infect. Immun. 2003, 71(4):1980-1987.
41. Willadsen P., Kemp D.H. Vaccination with concealed antigens for tick control. Parasitol. Today 1988, 4(7):196-198.
42. Willadsen P., Mckenna R.V., Riding G.A. Isolation from the cattle tick, Boophilus microplus, of antigenic material capable of eliciting a protective immunological response in the bovine host. Int. J. Parasitol. 1988, 18(2):183-189.